アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/03/31 | 1,887 | 1,891 | 1,878 | 1,883 | +5 | +0.3% | 7,095,000 |
2023/03/30 | 1,876 | 1,882 | 1,865.5 | 1,878 | -29.5 | -1.5% | 4,669,500 |
2023/03/29 | 1,882.5 | 1,908.5 | 1,872 | 1,907.5 | +15.5 | +0.8% | 5,944,500 |
2023/03/28 | 1,892.5 | 1,902 | 1,877.5 | 1,892 | +25.5 | +1.4% | 4,460,100 |
2023/03/27 | 1,850 | 1,872.5 | 1,847.5 | 1,866.5 | +21.5 | +1.2% | 3,539,200 |
2023/03/24 | 1,849 | 1,849 | 1,835 | 1,845 | +2 | +0.1% | 3,944,500 |
2023/03/23 | 1,854 | 1,854.5 | 1,826 | 1,843 | -23 | -1.2% | 4,885,700 |
2023/03/22 | 1,847 | 1,871.5 | 1,840.5 | 1,866 | +33.5 | +1.8% | 6,902,900 |
2023/03/20 | 1,851 | 1,856.5 | 1,831 | 1,832.5 | -18 | -1% | 5,130,500 |
2023/03/17 | 1,836.5 | 1,856 | 1,836 | 1,850.5 | +3 | +0.2% | 10,311,900 |
2023/03/16 | 1,837.5 | 1,852 | 1,823.5 | 1,847.5 | -24.5 | -1.3% | 5,949,300 |
2023/03/15 | 1,875.5 | 1,882 | 1,863.5 | 1,872 | -7.5 | -0.4% | 8,029,900 |
2023/03/14 | 1,876 | 1,896 | 1,862 | 1,879.5 | -6.5 | -0.3% | 8,712,300 |
2023/03/13 | 1,891 | 1,899.5 | 1,876 | 1,886 | -19 | -1% | 6,375,100 |
2023/03/10 | 1,925 | 1,927 | 1,905 | 1,905 | -30.5 | -1.6% | 9,228,600 |
2023/03/09 | 1,940 | 1,940.5 | 1,929 | 1,935.5 | +5.5 | +0.3% | 4,582,600 |
2023/03/08 | 1,923 | 1,933 | 1,915.5 | 1,930 | +12.5 | +0.7% | 4,966,800 |
2023/03/07 | 1,903 | 1,925.5 | 1,903 | 1,917.5 | +9 | +0.5% | 6,671,700 |
2023/03/06 | 1,920 | 1,925.5 | 1,903 | 1,908.5 | -3.5 | -0.2% | 6,433,300 |
2023/03/03 | 1,903.5 | 1,917 | 1,896 | 1,912 | +8.5 | +0.4% | 8,975,600 |
2023/03/02 | 1,903.5 | 1,914.5 | 1,897.5 | 1,903.5 | -7.5 | -0.4% | 7,613,600 |
2023/03/01 | 1,912.5 | 1,919 | 1,904.5 | 1,911 | -8 | -0.4% | 5,441,100 |
2023/02/28 | 1,923 | 1,938 | 1,915 | 1,919 | -4 | -0.2% | 8,016,900 |
2023/02/27 | 1,913 | 1,927 | 1,913 | 1,923 | +17 | +0.9% | 3,973,100 |
2023/02/24 | 1,912 | 1,914 | 1,893 | 1,906 | +15.5 | +0.8% | 6,264,000 |
2023/02/22 | 1,903.5 | 1,905.5 | 1,883.5 | 1,890.5 | -14 | -0.7% | 6,959,800 |
2023/02/21 | 1,890.5 | 1,914 | 1,887 | 1,904.5 | +18.5 | +1% | 5,532,100 |
2023/02/20 | 1,897 | 1,904 | 1,880.5 | 1,886 | -41 | -2.1% | 10,785,000 |
2023/02/17 | 1,915.5 | 1,933.5 | 1,914.5 | 1,927 | -6 | -0.3% | 4,360,700 |
2023/02/16 | 1,922 | 1,939.5 | 1,921.5 | 1,933 | +1.5 | +0.1% | 4,512,200 |
2023/02/15 | 1,930.5 | 1,937 | 1,925.5 | 1,931.5 | +1.5 | +0.1% | 4,016,600 |
2023/02/14 | 1,925 | 1,934 | 1,920 | 1,930 | +14.5 | +0.8% | 3,798,500 |
2023/02/13 | 1,915 | 1,930.5 | 1,905 | 1,915.5 | +0.5 | ±0% | 4,870,300 |
2023/02/10 | 1,917 | 1,926 | 1,909 | 1,915 | -8.5 | -0.4% | 7,706,100 |
2023/02/09 | 1,919 | 1,931.5 | 1,919 | 1,923.5 | -9 | -0.5% | 6,100,900 |
2023/02/08 | 1,929.5 | 1,943.5 | 1,921.5 | 1,932.5 | +18.5 | +1% | 6,181,200 |
2023/02/07 | 1,932.5 | 1,960.5 | 1,911.5 | 1,914 | +12.5 | +0.7% | 9,338,800 |
2023/02/06 | 1,910 | 1,911.5 | 1,897 | 1,901.5 | +12 | +0.6% | 4,306,700 |
2023/02/03 | 1,899.5 | 1,909 | 1,888 | 1,889.5 | -10.5 | -0.6% | 4,204,000 |
2023/02/02 | 1,874.5 | 1,904.5 | 1,874 | 1,900 | -2 | -0.1% | 6,000,000 |
2023/02/01 | 1,918.5 | 1,923 | 1,899 | 1,902 | -10.5 | -0.5% | 4,218,100 |
2023/01/31 | 1,925.5 | 1,935 | 1,912 | 1,912.5 | -1 | -0.1% | 4,739,100 |
2023/01/30 | 1,919 | 1,929.5 | 1,910.5 | 1,913.5 | -25 | -1.3% | 4,889,800 |
2023/01/27 | 1,954 | 1,957.5 | 1,930 | 1,938.5 | -36.5 | -1.8% | 4,857,400 |
2023/01/26 | 2,002 | 2,009 | 1,969.5 | 1,975 | -2.5 | -0.1% | 5,045,000 |
2023/01/25 | 1,971 | 1,989.5 | 1,969 | 1,977.5 | +9.5 | +0.5% | 4,901,000 |
2023/01/24 | 1,970.5 | 1,977.5 | 1,946 | 1,968 | +15.5 | +0.8% | 4,321,300 |
2023/01/23 | 1,973.5 | 1,975 | 1,951.5 | 1,952.5 | -6 | -0.3% | 3,995,500 |
2023/01/20 | 1,943 | 1,958.5 | 1,928 | 1,958.5 | +18.5 | +1% | 4,290,300 |
2023/01/19 | 1,939.5 | 1,946 | 1,927.5 | 1,940 | -20 | -1% | 4,644,300 |
451~
500
件表示中 / 3631件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 151,400円 | +18.5% | -96.0% | 4.89% | 193.61倍 | 1.77倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
武 田 | 420,900円 | +7.7% | +206.9% | 4.66% | 56.54倍 | 0.96倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 813,600円 | +14.4% | +120.8% | 1.47% | 18.21倍 | 1.67倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 229,000円 | +5.7% | +3.9% | 2.50% | 11.39倍 | 1.51倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 462,100円 | +1.7% | -2.9% | 3.46% | 30.32倍 | 1.59倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム